ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(11), P. 17137 - 17149
Published: Oct. 27, 2021
The
COVID-19
pandemic
made
clear
how
our
society
requires
quickly
available
tools
to
address
emerging
healthcare
issues.
Diagnostic
assays
and
devices
are
used
every
day
screen
for
positive
patients,
with
the
aim
decide
appropriate
treatment
containment
measures.
In
this
context,
we
would
have
expected
see
use
of
most
recent
diagnostic
technologies
worldwide,
including
advanced
ones
such
as
nano-biosensors
capable
provide
faster,
more
sensitive,
cheaper,
high-throughput
results
than
standard
polymerase
chain
reaction
lateral
flow
assays.
Here
discuss
why
that
has
not
been
case
all
exciting
strategies
published
on
a
daily
basis
in
peer-reviewed
journals
yet
successful
reaching
market
being
implemented
clinical
practice.
Nature,
Journal Year:
2022,
Volume and Issue:
609(7925), P. 101 - 108
Published: July 7, 2022
Abstract
As
SARS-CoV-2
continues
to
spread
and
evolve,
detecting
emerging
variants
early
is
critical
for
public
health
interventions.
Inferring
lineage
prevalence
by
clinical
testing
infeasible
at
scale,
especially
in
areas
with
limited
resources,
participation,
or
and/or
sequencing
capacity,
which
can
also
introduce
biases
1–3
.
RNA
concentration
wastewater
successfully
tracks
regional
infection
dynamics
provides
less
biased
abundance
estimates
than
4,5
Tracking
virus
genomic
sequences
would
improve
community
detect
variants.
However,
two
factors
limit
wastewater-based
surveillance:
low-quality
sequence
data
inability
estimate
relative
mixed
samples.
Here
we
resolve
these
issues
perform
a
high-resolution,
295-day
effort,
the
controlled
environment
of
large
university
campus
broader
context
surrounding
county.
We
developed
deployed
improved
protocols
deconvolution
software
that
fully
multiple
strains
from
wastewater.
detected
concern
up
14
days
earlier
samples,
identified
instances
not
captured
surveillance.
Our
study
scalable
solution
surveillance
allows
detection
identification
cryptic
transmission.
MMWR Morbidity and Mortality Weekly Report,
Journal Year:
2022,
Volume and Issue:
71(13), P. 489 - 494
Published: March 25, 2022
COVID-19
testing
provides
information
regarding
exposure
and
transmission
risks,
guides
preventative
measures
(e.g.,
if
when
to
start
end
isolation
quarantine),
identifies
opportunities
for
appropriate
treatments,
helps
assess
disease
prevalence
(1).
At-home
rapid
antigen
tests
(at-home
tests)
are
a
convenient
accessible
alternative
laboratory-based
diagnostic
nucleic
acid
amplification
(NAATs)
SARS-CoV-2,
the
virus
that
causes
(2-4).
With
emergence
of
SARS-CoV-2
B.1.617.2
(Delta)
B.1.1.529
(Omicron)
variants
in
2021,
demand
at-home
increased
Advanced Optical Materials,
Journal Year:
2023,
Volume and Issue:
11(14)
Published: April 26, 2023
Abstract
With
the
development
of
Raman
spectroscopy
and
expansion
its
application
domains,
conventional
methods
for
spectral
data
analysis
have
manifested
many
limitations.
Exploring
new
approaches
to
facilitate
has
become
an
area
intensifying
focus
research.
It
been
demonstrated
that
machine
learning
techniques
can
more
efficiently
extract
valuable
information
from
data,
creating
unprecedented
opportunities
analytical
science.
This
paper
outlines
traditional
recently
developed
statistical
are
commonly
used
in
(ML)
ML‐algorithms
different
spectroscopy‐based
classification
recognition
applications.
The
include
Principal
Component
Analysis,
K‐Nearest
Neighbor,
Random
Forest,
Support
Vector
Machine,
as
well
neural
network‐based
deep
algorithms
such
Artificial
Neural
Networks,
Convolutional
etc.
bulk
review
is
dedicated
research
advances
applied
several
fields,
including
material
science,
biomedical
applications,
food
others,
which
reached
impressive
levels
accuracy.
combination
offers
achieve
high
throughput
fast
identification
these
fields.
limitations
current
studies
also
discussed
perspectives
on
future
provided.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2023,
Volume and Issue:
12
Published: Jan. 5, 2023
The
coronavirus
disease
2019
(COVID-19)
pandemic
has
prompted
a
lot
of
questions
globally
regarding
the
range
information
about
virus’s
possible
routes
transmission,
diagnostics,
and
therapeutic
tools.
Worldwide
studies
have
pointed
out
importance
monitoring
early
surveillance
techniques
based
on
identification
viral
RNA
in
wastewater.
These
indicated
presence
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
human
feces,
which
is
shed
via
excreta
including
mucus,
saliva,
sputum.
Subsequently,
they
get
dumped
into
wastewater,
their
wastewater
provides
possibility
using
it
as
tool
to
help
prevent
eradicate
virus.
Its
still
done
many
regions
worldwide
serves
an
“warning
signal”;
however,
limitations
also
been
identified.
The Science of The Total Environment,
Journal Year:
2025,
Volume and Issue:
962, P. 178455 - 178455
Published: Jan. 1, 2025
Wastewater-based
surveillance
(WBS)
can
monitor
for
the
presence
of
human
health
pathogens
in
population.
During
COVID-19,
WBS
was
widely
used
to
determine
wastewater
SARS-CoV-2
RNA
concentration
(concentrations)
providing
information
on
community
COVID-19
cases
(cases).
However,
studies
examining
relationship
between
concentrations
and
tend
be
localised
or
focussed
small-scale
institutional
settings.
Few
have
examined
this
multiple
settings,
over
long
periods,
with
large
sample
numbers,
nor
attempted
quantify
detail
how
catchment
characteristics
affected
these.
This
18-month
study
(07/20-12/21)
explored
correlation
quantitative
using
censored
regression.
Our
analysis
>94,000
samples
collected
from
452
diverse
sampling
sites
(259
Sewage
Treatment
Works
(STW)
193
Sewer
Network
Sites
(SNS))
covering
~65
%
English
Wastewater
were
linked
~6
million
diagnostically
confirmed
cases.
High
coefficients
found
(STW:
median
r
=
0.66,
IQR:
0.57-0.74;
SNS:
0.65,
0.54-0.74).
The
(regression
coefficient)
variable
catchments.
Catchment
(e.g.
size
population
grab
vs
automated
sampling)
had
significant
but
small
effects
regression
coefficients.
last
six
months
reduced
became
highly
coincided
a
shift
towards
younger
cases,
vaccinated
rapid
emergence
variant
Omicron.
programme
rapidly
introduced
at
scale
during
COVID-19.
Laboratory
methods
evolved
catchments
characteristics.
Despite
diversity,
findings
indicate
that
provides
an
effective
proxy
establishing
dynamics
across
wide
variety
communities.
While
there
is
potential
predicting
concentration,
may
more
smaller
scales.
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: July 28, 2021
Abstract
Heterogeneous
immunoassays
such
as
ELISA
have
become
indispensable
in
modern
bioanalysis,
yet
translation
into
point-of-care
assays
is
hindered
by
their
dependence
on
external
calibration
and
multiple
washing
incubation
steps.
Here,
we
introduce
RAPPID
(Ratiometric
Plug-and-Play
Immunodiagnostics),
a
mix-and-measure
homogeneous
immunoassay
platform
that
combines
highly
specific
antibody-based
detection
with
ratiometric
bioluminescent
readout.
The
concept
entails
analyte-induced
complementation
of
split
NanoLuc
luciferase
fragments,
photoconjugated
to
an
antibody
sandwich
pair
via
protein
G
adapters.
Introduction
calibrator
provides
robust
signal
allows
direct
in-sample
quantitative
measurements
complex
media
blood
plasma.
We
developed
sensors
allow
low-picomolar
several
biomarkers,
anti-drug
antibodies,
therapeutic
both
SARS-CoV-2
spike
anti-SARS-CoV-2
antibodies.
With
its
easy-to-implement
standardized
workflow,
attractive,
fast,
low-cost
alternative
traditional
immunoassays,
academic
setting,
clinical
laboratories,
for
applications.
ACS Synthetic Biology,
Journal Year:
2021,
Volume and Issue:
11(1), P. 406 - 419
Published: Dec. 23, 2021
Simple,
rapid,
specific,
and
sensitive
point-of-care
detection
methods
are
needed
to
contain
the
spread
of
SARS-CoV-2.
CRISPR/Cas9-based
lateral
flow
assays
emerging
as
a
powerful
alternative
for
COVID-19
diagnostics.
Here,
we
developed
Bio-SCAN
(biotin-coupled
specific
CRISPR-based
assay
nucleic
acid
detection)
an
accurate
pathogen
platform
that
requires
no
sophisticated
equipment
or
technical
expertise.
detects
SARS-CoV-2
genome
in
less
than
1
h
from
sample
collection
result.
In
first
step,
target
sequence
is
isothermally
amplified
15
min
via
recombinase
polymerase
amplification
before
being
precisely
detected
by
biotin-labeled
nuclease-dead
SpCas9
(dCas9)
on
commercially
available
strips.
The
resulting
readout
visible
naked
eye.
Compared
other
CRISPR-Cas-based
assays,
additional
reporters,
probes,
enhancers,
reagents,
devices
interpret
results.
highly
successfully
clinically
relevant
level
(4
copies/μL)
synthetic
RNA
genome.
Similarly,
showed
100%
negative
96%
positive
predictive
agreement
with
RT-qPCR
results
when
using
clinical
samples
(86
nasopharyngeal
swab
samples).
Furthermore,
incorporating
variant-specific
sgRNAs
reaction
allowed
efficiently
distinguish
between
α,
β,
δ
variants.
Also,
our
confirmed
reagents
have
long
shelf
life
can
be
assembled
locally
nonlaboratory
limited-resource
settings.
compatible
quick
extraction
protocol.
Our
highlight
potential
promising
diagnostic
facilitate
low-cost
mass
screening
Lab on a Chip,
Journal Year:
2021,
Volume and Issue:
21(23), P. 4517 - 4548
Published: Jan. 1, 2021
In
this
review,
we
provide
an
overview
of
developments
in
point-of-care
(POC)
diagnostics
during
the
COVID-19
pandemic.
We
review
these
advances
within
framework
a
holistic
POC
ecosystem,
focusing
on
points
interest
-
both
technological
and
non-technological
to
researchers
test
developers.
Technologically,
design
choices
assay
chemistry,
microfluidics,
instrumentation
towards
nucleic
acid
protein
detection
for
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2),
away
from
lab
bench,
that
supported
unprecedented
rapid
development,
scale
up,
deployment
devices.
describe
common
features
technologies
obtained
Emergency
Use
Authorization
(EUA)
acid,
antigen,
antibody
tests,
how
tests
fit
into
four
distinct
use
cases.
conclude
with
implications
future
pandemics,
infectious
disease
monitoring,
digital
health.